Singapore, June 24 -- Bridging China and the Middle East to Strengthen Regional Supply chains and Impact Millions of Cancer Patients

On the sidelines of CPHI China 2025, EVA Pharma, one of the leading pharmaceutical companies driving healthcare innovation and access across the Middle East and Africa, and CHICO Pharmaceutical, a high-tech enterprise specializing in CDMO services for pharmaceutical raw materials and the production of high-end pharmaceutical intermediates, signed a landmark Memorandum of Understanding (MoU) to establish a collaboration focused on the technology transfer and localized synthesis of oncology Active Pharmaceutical Ingredients (APIs).

The agreement covers the tech transfer of 10 advanced small-molecule anti-neo...